The FDA’s National Center for Toxicological Research (NCTR) and precisionFDA have officially launched the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.
Phase 1 of the challenge will run through July 8Th and an optional Phase 2 will run from July 11th-July 26th. Challenge winners will be publicly recognized by the FDA and invited to contribute to a manuscript and webinar discussing the challenge and their submission results. To learn more, visit the challenge site here https://go.usa.gov/xumSw.
If you have any additional questions, don’t hesitate to post them in the thread and we will answer them as quickly as possible!